Literature DB >> 26233892

Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis.

Xiaodong Sun1, Changsheng Xing1, Xiaoying Fu2, Jie Li1, Baotong Zhang1, Henry F Frierson3, Jin-Tang Dong4.   

Abstract

The phosphatase and tensin homolog (PTEN) and the zinc finger homeobox 3 (ZFHX3)/AT-motif binding factor 1 (ATBF1) genes have been established as tumor suppressor genes in prostate cancer by their frequent deletions and mutations in human prostate cancer and by the formation of mouse prostatic intraepithelial neoplasia (mPIN) or tumor by their deletions in mouse prostates. However, whether ZFHX3/ATBF1 deletion together with PTEN deletion facilitates prostatic tumorigenesis is unknown. In this study, we simultaneously deleted both genes in mouse prostatic epithelia and performed histological and molecular analyses. While deletion of one Pten allele alone caused low-grade (LG) mPIN as previously reported, concurrent deletion of Zfhx3/Atbf1 promoted the progression to high-grade (HG) mPIN or early carcinoma. Zfhx3/Atbf1 and Pten deletions together increased cell proliferation, disrupted the smooth muscle layer between epithelium and stroma, and increased the number of apoptotic cells. Deletion of both genes also accelerated the activation of Akt and Erk1/2 oncoproteins. These results suggest an additive effect of ZFHX3/ATBF1 and PTEN deletions on the development and progression of prostate neoplasia.
Copyright © 2015 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ATBF1; PTEN; Prostate cancer; ZFHX3; mPIN

Mesh:

Substances:

Year:  2015        PMID: 26233892      PMCID: PMC4874175          DOI: 10.1016/j.jgg.2015.06.004

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  43 in total

1.  Germline ATBF1 mutations and prostate cancer risk.

Authors:  Junyan Xu; Jurga Sauvageot; Charles M Ewing; Jielin Sun; Wennuan Liu; Sarah D Isaacs; Kathleen E Wiley; Lina Diaz; S Lilly Zheng; Patrick C Walsh; William B Isaacs
Journal:  Prostate       Date:  2006-07-01       Impact factor: 4.104

2.  Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

Authors:  Hui Gao; Xuesong Ouyang; Whitney A Banach-Petrosky; William L Gerald; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

3.  Genetic alterations of the ATBF1 gene in gastric cancer.

Authors:  Yong Gu Cho; Jae Hwi Song; Chang Jae Kim; Youn Soo Lee; Su Young Kim; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

4.  Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.

Authors:  Zongxiang Zhou; Andrea Flesken-Nikitin; David C Corney; Wei Wang; David W Goodrich; Pradip Roy-Burman; Alexander Yu Nikitin
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  Tenets of PTEN tumor suppression.

Authors:  Leonardo Salmena; Arkaitz Carracedo; Pier Paolo Pandolfi
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

6.  Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.

Authors:  Xuesong Ouyang; Walter J Jessen; Hikmat Al-Ahmadie; Angel M Serio; Yong Lin; Weichung-Joseph Shih; Victor E Reuter; Peter T Scardino; Michael M Shen; Bruce J Aronow; Andrew J Vickers; William L Gerald; Cory Abate-Shen
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 7.  Advances in mouse models of prostate cancer.

Authors:  Imran Ahmad; Owen J Sansom; Hing Y Leung
Journal:  Expert Rev Mol Med       Date:  2008-06-09       Impact factor: 5.600

8.  Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate.

Authors:  Long-jiang Shao; Heidi Y Shi; Gustavo Ayala; David Rowley; Ming Zhang
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.

Authors:  C J Kim; J H Song; Y G Cho; Z Cao; Y S Lee; S W Nam; J Y Lee; W S Park
Journal:  Histopathology       Date:  2008-02-23       Impact factor: 5.087

10.  Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.

Authors:  Kazuharu Kai; Zhenhuan Zhang; Hiroko Yamashita; Yutaka Yamamoto; Yutaka Miura; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2008-09-16       Impact factor: 4.430

View more
  8 in total

1.  SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.

Authors:  Rui Wu; Jiali Fang; Mingcheng Liu; Jun A; Jinming Liu; Wenxuan Chen; Juan Li; Gui Ma; Zhiqian Zhang; Baotong Zhang; Liya Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-05       Impact factor: 5.157

2.  Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.

Authors:  Dan Zhao; Gui Ma; Xiaolin Zhang; Yuan He; Mei Li; Xueying Han; Liya Fu; Xue-Yuan Dong; Tamas Nagy; Qiang Zhao; Li Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

3.  Inducible Knockout of Mouse Zfhx3 Emphasizes Its Key Role in Setting the Pace and Amplitude of the Adult Circadian Clock.

Authors:  Ashleigh G Wilcox; Lucie Vizor; Michael J Parsons; Gareth Banks; Patrick M Nolan
Journal:  J Biol Rhythms       Date:  2017-08-17       Impact factor: 3.182

4.  ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells.

Authors:  Qingxia Hu; Baotong Zhang; Rui Chen; Changying Fu; Jun A; Xing Fu; Juan Li; Liya Fu; Zhiqian Zhang; Jin-Tang Dong
Journal:  Oncogenesis       Date:  2019-04-12       Impact factor: 7.485

Review 5.  Signal Crosstalk and the Role of Estrogen Receptor beta (ERβ) in Prostate Cancer.

Authors:  Jialin Li; Quanliang Liu; Chengming Jiang
Journal:  Med Sci Monit       Date:  2022-04-06

6.  Detection of disease-causing mutations in prostate cancer by NGS sequencing.

Authors:  Alessandra Mangolini; Christian Rocca; Cristian Bassi; Carmelo Ippolito; Massimo Negrini; Lucio Dell'Atti; Giovanni Lanza; Roberta Gafà; Nicoletta Bianchi; Paolo Pinton; Gianluca Aguiari
Journal:  Cell Biol Int       Date:  2022-04-06       Impact factor: 4.473

Review 7.  Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.

Authors:  Nieves Lara-Ureña; Vahid Jafari; Mario García-Domínguez
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

8.  AR imposes different effects on ZFHX3 transcription depending on androgen status in prostate cancer cells.

Authors:  Xing Fu; Zhiqian Zhang; Mingcheng Liu; Juan Li; Jun A; Liya Fu; Chenyang Huang; Jin-Tang Dong
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.